nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—HTR2C—Sorafenib—thyroid cancer	0.126	0.229	CbGbCtD
Citalopram—CYP2B6—Sorafenib—thyroid cancer	0.0784	0.142	CbGbCtD
Citalopram—CYP2C19—Sorafenib—thyroid cancer	0.0498	0.0902	CbGbCtD
Citalopram—CYP2B6—Doxorubicin—thyroid cancer	0.0476	0.0861	CbGbCtD
Citalopram—CYP1A2—Sorafenib—thyroid cancer	0.0459	0.0832	CbGbCtD
Citalopram—ABCB1—Sorafenib—thyroid cancer	0.0402	0.0728	CbGbCtD
Citalopram—CYP3A4—Vandetanib—thyroid cancer	0.0399	0.0724	CbGbCtD
Citalopram—CYP2D6—Sorafenib—thyroid cancer	0.0379	0.0686	CbGbCtD
Citalopram—ABCB1—Doxorubicin—thyroid cancer	0.0244	0.0442	CbGbCtD
Citalopram—CYP3A4—Sorafenib—thyroid cancer	0.0241	0.0436	CbGbCtD
Citalopram—CYP2D6—Doxorubicin—thyroid cancer	0.023	0.0416	CbGbCtD
Citalopram—CYP3A4—Doxorubicin—thyroid cancer	0.0146	0.0265	CbGbCtD
Citalopram—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000199	0.000453	CcSEcCtD
Citalopram—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000199	0.000453	CcSEcCtD
Citalopram—Hypokalaemia—Doxorubicin—thyroid cancer	0.000199	0.000451	CcSEcCtD
Citalopram—Angina pectoris—Epirubicin—thyroid cancer	0.000199	0.000451	CcSEcCtD
Citalopram—Rash—Sorafenib—thyroid cancer	0.000198	0.000449	CcSEcCtD
Citalopram—Dermatitis—Sorafenib—thyroid cancer	0.000198	0.000449	CcSEcCtD
Citalopram—Breast disorder—Doxorubicin—thyroid cancer	0.000197	0.000448	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000196	0.000446	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000196	0.000446	CcSEcCtD
Citalopram—Headache—Sorafenib—thyroid cancer	0.000196	0.000446	CcSEcCtD
Citalopram—Bronchitis—Epirubicin—thyroid cancer	0.000196	0.000445	CcSEcCtD
Citalopram—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000195	0.000443	CcSEcCtD
Citalopram—Pancytopenia—Epirubicin—thyroid cancer	0.000194	0.00044	CcSEcCtD
Citalopram—Gastritis—Doxorubicin—thyroid cancer	0.000193	0.000439	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000192	0.000437	CcSEcCtD
Citalopram—Muscular weakness—Doxorubicin—thyroid cancer	0.000192	0.000437	CcSEcCtD
Citalopram—Dysuria—Epirubicin—thyroid cancer	0.000191	0.000433	CcSEcCtD
Citalopram—Abdominal distension—Doxorubicin—thyroid cancer	0.00019	0.000431	CcSEcCtD
Citalopram—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000189	0.00043	CcSEcCtD
Citalopram—Influenza—Doxorubicin—thyroid cancer	0.000189	0.000428	CcSEcCtD
Citalopram—Asthma—Doxorubicin—thyroid cancer	0.000189	0.000428	CcSEcCtD
Citalopram—Dysphagia—Doxorubicin—thyroid cancer	0.000189	0.000428	CcSEcCtD
Citalopram—Pollakiuria—Epirubicin—thyroid cancer	0.000188	0.000428	CcSEcCtD
Citalopram—Eosinophilia—Doxorubicin—thyroid cancer	0.000187	0.000424	CcSEcCtD
Citalopram—Nausea—Sorafenib—thyroid cancer	0.000186	0.000423	CcSEcCtD
Citalopram—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000186	0.000423	CcSEcCtD
Citalopram—Weight increased—Epirubicin—thyroid cancer	0.000185	0.000421	CcSEcCtD
Citalopram—Pancreatitis—Doxorubicin—thyroid cancer	0.000185	0.00042	CcSEcCtD
Citalopram—Weight decreased—Epirubicin—thyroid cancer	0.000184	0.000419	CcSEcCtD
Citalopram—Hyperglycaemia—Epirubicin—thyroid cancer	0.000184	0.000418	CcSEcCtD
Citalopram—Angina pectoris—Doxorubicin—thyroid cancer	0.000184	0.000417	CcSEcCtD
Citalopram—Pneumonia—Epirubicin—thyroid cancer	0.000183	0.000415	CcSEcCtD
Citalopram—Infestation—Epirubicin—thyroid cancer	0.000182	0.000413	CcSEcCtD
Citalopram—Infestation NOS—Epirubicin—thyroid cancer	0.000182	0.000413	CcSEcCtD
Citalopram—Bronchitis—Doxorubicin—thyroid cancer	0.000181	0.000412	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00018	0.000409	CcSEcCtD
Citalopram—Pancytopenia—Doxorubicin—thyroid cancer	0.000179	0.000407	CcSEcCtD
Citalopram—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000178	0.000405	CcSEcCtD
Citalopram—Stomatitis—Epirubicin—thyroid cancer	0.000177	0.000402	CcSEcCtD
Citalopram—Jaundice—Epirubicin—thyroid cancer	0.000177	0.000402	CcSEcCtD
Citalopram—Urinary tract infection—Epirubicin—thyroid cancer	0.000177	0.000401	CcSEcCtD
Citalopram—Conjunctivitis—Epirubicin—thyroid cancer	0.000177	0.000401	CcSEcCtD
Citalopram—Dysuria—Doxorubicin—thyroid cancer	0.000176	0.000401	CcSEcCtD
Citalopram—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000175	0.000398	CcSEcCtD
Citalopram—Sweating—Epirubicin—thyroid cancer	0.000174	0.000396	CcSEcCtD
Citalopram—Pollakiuria—Doxorubicin—thyroid cancer	0.000174	0.000396	CcSEcCtD
Citalopram—Haematuria—Epirubicin—thyroid cancer	0.000173	0.000394	CcSEcCtD
Citalopram—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000172	0.000391	CcSEcCtD
Citalopram—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000172	0.00039	CcSEcCtD
Citalopram—Weight increased—Doxorubicin—thyroid cancer	0.000172	0.00039	CcSEcCtD
Citalopram—Epistaxis—Epirubicin—thyroid cancer	0.000171	0.000389	CcSEcCtD
Citalopram—Weight decreased—Doxorubicin—thyroid cancer	0.000171	0.000388	CcSEcCtD
Citalopram—Sinusitis—Epirubicin—thyroid cancer	0.000171	0.000387	CcSEcCtD
Citalopram—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00017	0.000386	CcSEcCtD
Citalopram—Agranulocytosis—Epirubicin—thyroid cancer	0.00017	0.000385	CcSEcCtD
Citalopram—Pneumonia—Doxorubicin—thyroid cancer	0.000169	0.000384	CcSEcCtD
Citalopram—Infestation NOS—Doxorubicin—thyroid cancer	0.000168	0.000382	CcSEcCtD
Citalopram—Infestation—Doxorubicin—thyroid cancer	0.000168	0.000382	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000167	0.000379	CcSEcCtD
Citalopram—Bradycardia—Epirubicin—thyroid cancer	0.000166	0.000377	CcSEcCtD
Citalopram—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000165	0.000374	CcSEcCtD
Citalopram—Haemoglobin—Epirubicin—thyroid cancer	0.000164	0.000372	CcSEcCtD
Citalopram—Stomatitis—Doxorubicin—thyroid cancer	0.000164	0.000372	CcSEcCtD
Citalopram—Jaundice—Doxorubicin—thyroid cancer	0.000164	0.000372	CcSEcCtD
Citalopram—Rhinitis—Epirubicin—thyroid cancer	0.000164	0.000372	CcSEcCtD
Citalopram—Conjunctivitis—Doxorubicin—thyroid cancer	0.000163	0.000371	CcSEcCtD
Citalopram—Urinary tract infection—Doxorubicin—thyroid cancer	0.000163	0.000371	CcSEcCtD
Citalopram—Haemorrhage—Epirubicin—thyroid cancer	0.000163	0.000371	CcSEcCtD
Citalopram—Hepatitis—Epirubicin—thyroid cancer	0.000163	0.000371	CcSEcCtD
Citalopram—Hypoaesthesia—Epirubicin—thyroid cancer	0.000162	0.000369	CcSEcCtD
Citalopram—Pharyngitis—Epirubicin—thyroid cancer	0.000162	0.000368	CcSEcCtD
Citalopram—Sweating—Doxorubicin—thyroid cancer	0.000161	0.000366	CcSEcCtD
Citalopram—Urinary tract disorder—Epirubicin—thyroid cancer	0.000161	0.000366	CcSEcCtD
Citalopram—Oedema peripheral—Epirubicin—thyroid cancer	0.000161	0.000365	CcSEcCtD
Citalopram—Haematuria—Doxorubicin—thyroid cancer	0.00016	0.000364	CcSEcCtD
Citalopram—Connective tissue disorder—Epirubicin—thyroid cancer	0.00016	0.000364	CcSEcCtD
Citalopram—Urethral disorder—Epirubicin—thyroid cancer	0.00016	0.000363	CcSEcCtD
Citalopram—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000159	0.000361	CcSEcCtD
Citalopram—Epistaxis—Doxorubicin—thyroid cancer	0.000159	0.00036	CcSEcCtD
Citalopram—Sinusitis—Doxorubicin—thyroid cancer	0.000158	0.000358	CcSEcCtD
Citalopram—Visual impairment—Epirubicin—thyroid cancer	0.000157	0.000357	CcSEcCtD
Citalopram—Agranulocytosis—Doxorubicin—thyroid cancer	0.000157	0.000356	CcSEcCtD
Citalopram—Erythema multiforme—Epirubicin—thyroid cancer	0.000154	0.00035	CcSEcCtD
Citalopram—Bradycardia—Doxorubicin—thyroid cancer	0.000154	0.000349	CcSEcCtD
Citalopram—Eye disorder—Epirubicin—thyroid cancer	0.000152	0.000346	CcSEcCtD
Citalopram—Tinnitus—Epirubicin—thyroid cancer	0.000152	0.000346	CcSEcCtD
Citalopram—Haemoglobin—Doxorubicin—thyroid cancer	0.000152	0.000345	CcSEcCtD
Citalopram—Flushing—Epirubicin—thyroid cancer	0.000151	0.000344	CcSEcCtD
Citalopram—Cardiac disorder—Epirubicin—thyroid cancer	0.000151	0.000344	CcSEcCtD
Citalopram—Rhinitis—Doxorubicin—thyroid cancer	0.000151	0.000344	CcSEcCtD
Citalopram—Haemorrhage—Doxorubicin—thyroid cancer	0.000151	0.000343	CcSEcCtD
Citalopram—Hepatitis—Doxorubicin—thyroid cancer	0.000151	0.000343	CcSEcCtD
Citalopram—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00015	0.000341	CcSEcCtD
Citalopram—Pharyngitis—Doxorubicin—thyroid cancer	0.00015	0.00034	CcSEcCtD
Citalopram—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000149	0.000339	CcSEcCtD
Citalopram—Oedema peripheral—Doxorubicin—thyroid cancer	0.000149	0.000338	CcSEcCtD
Citalopram—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000148	0.000337	CcSEcCtD
Citalopram—Angiopathy—Epirubicin—thyroid cancer	0.000148	0.000336	CcSEcCtD
Citalopram—Urethral disorder—Doxorubicin—thyroid cancer	0.000148	0.000336	CcSEcCtD
Citalopram—Immune system disorder—Epirubicin—thyroid cancer	0.000147	0.000335	CcSEcCtD
Citalopram—Mediastinal disorder—Epirubicin—thyroid cancer	0.000147	0.000334	CcSEcCtD
Citalopram—Chills—Epirubicin—thyroid cancer	0.000146	0.000333	CcSEcCtD
Citalopram—Arrhythmia—Epirubicin—thyroid cancer	0.000146	0.000331	CcSEcCtD
Citalopram—Visual impairment—Doxorubicin—thyroid cancer	0.000145	0.00033	CcSEcCtD
Citalopram—Alopecia—Epirubicin—thyroid cancer	0.000144	0.000327	CcSEcCtD
Citalopram—Mental disorder—Epirubicin—thyroid cancer	0.000143	0.000325	CcSEcCtD
Citalopram—Erythema multiforme—Doxorubicin—thyroid cancer	0.000143	0.000324	CcSEcCtD
Citalopram—Malnutrition—Epirubicin—thyroid cancer	0.000142	0.000323	CcSEcCtD
Citalopram—Erythema—Epirubicin—thyroid cancer	0.000142	0.000323	CcSEcCtD
Citalopram—Eye disorder—Doxorubicin—thyroid cancer	0.000141	0.00032	CcSEcCtD
Citalopram—Tinnitus—Doxorubicin—thyroid cancer	0.000141	0.00032	CcSEcCtD
Citalopram—Flushing—Doxorubicin—thyroid cancer	0.00014	0.000318	CcSEcCtD
Citalopram—Cardiac disorder—Doxorubicin—thyroid cancer	0.00014	0.000318	CcSEcCtD
Citalopram—Flatulence—Epirubicin—thyroid cancer	0.00014	0.000318	CcSEcCtD
Citalopram—Tension—Epirubicin—thyroid cancer	0.000139	0.000317	CcSEcCtD
Citalopram—Dysgeusia—Epirubicin—thyroid cancer	0.000139	0.000316	CcSEcCtD
Citalopram—Nervousness—Epirubicin—thyroid cancer	0.000138	0.000313	CcSEcCtD
Citalopram—Back pain—Epirubicin—thyroid cancer	0.000137	0.000312	CcSEcCtD
Citalopram—Angiopathy—Doxorubicin—thyroid cancer	0.000137	0.000311	CcSEcCtD
Citalopram—Muscle spasms—Epirubicin—thyroid cancer	0.000137	0.00031	CcSEcCtD
Citalopram—Immune system disorder—Doxorubicin—thyroid cancer	0.000136	0.00031	CcSEcCtD
Citalopram—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000136	0.000309	CcSEcCtD
Citalopram—Chills—Doxorubicin—thyroid cancer	0.000135	0.000308	CcSEcCtD
Citalopram—Arrhythmia—Doxorubicin—thyroid cancer	0.000135	0.000306	CcSEcCtD
Citalopram—Vision blurred—Epirubicin—thyroid cancer	0.000134	0.000304	CcSEcCtD
Citalopram—Alopecia—Doxorubicin—thyroid cancer	0.000133	0.000303	CcSEcCtD
Citalopram—Mental disorder—Doxorubicin—thyroid cancer	0.000132	0.0003	CcSEcCtD
Citalopram—Ill-defined disorder—Epirubicin—thyroid cancer	0.000132	0.000299	CcSEcCtD
Citalopram—Erythema—Doxorubicin—thyroid cancer	0.000131	0.000299	CcSEcCtD
Citalopram—Malnutrition—Doxorubicin—thyroid cancer	0.000131	0.000299	CcSEcCtD
Citalopram—Anaemia—Epirubicin—thyroid cancer	0.000131	0.000298	CcSEcCtD
Citalopram—Agitation—Epirubicin—thyroid cancer	0.000131	0.000296	CcSEcCtD
Citalopram—Flatulence—Doxorubicin—thyroid cancer	0.000129	0.000294	CcSEcCtD
Citalopram—Tension—Doxorubicin—thyroid cancer	0.000129	0.000293	CcSEcCtD
Citalopram—Dysgeusia—Doxorubicin—thyroid cancer	0.000129	0.000292	CcSEcCtD
Citalopram—Malaise—Epirubicin—thyroid cancer	0.000128	0.000291	CcSEcCtD
Citalopram—Nervousness—Doxorubicin—thyroid cancer	0.000128	0.00029	CcSEcCtD
Citalopram—Vertigo—Epirubicin—thyroid cancer	0.000128	0.00029	CcSEcCtD
Citalopram—Syncope—Epirubicin—thyroid cancer	0.000127	0.000289	CcSEcCtD
Citalopram—Leukopenia—Epirubicin—thyroid cancer	0.000127	0.000289	CcSEcCtD
Citalopram—Back pain—Doxorubicin—thyroid cancer	0.000127	0.000289	CcSEcCtD
Citalopram—Muscle spasms—Doxorubicin—thyroid cancer	0.000126	0.000287	CcSEcCtD
Citalopram—Palpitations—Epirubicin—thyroid cancer	0.000126	0.000285	CcSEcCtD
Citalopram—Loss of consciousness—Epirubicin—thyroid cancer	0.000125	0.000284	CcSEcCtD
Citalopram—Cough—Epirubicin—thyroid cancer	0.000124	0.000282	CcSEcCtD
Citalopram—Vision blurred—Doxorubicin—thyroid cancer	0.000124	0.000281	CcSEcCtD
Citalopram—Convulsion—Epirubicin—thyroid cancer	0.000123	0.00028	CcSEcCtD
Citalopram—Hypertension—Epirubicin—thyroid cancer	0.000123	0.000279	CcSEcCtD
Citalopram—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000122	0.000277	CcSEcCtD
Citalopram—Anaemia—Doxorubicin—thyroid cancer	0.000121	0.000276	CcSEcCtD
Citalopram—Arthralgia—Epirubicin—thyroid cancer	0.000121	0.000275	CcSEcCtD
Citalopram—Myalgia—Epirubicin—thyroid cancer	0.000121	0.000275	CcSEcCtD
Citalopram—Chest pain—Epirubicin—thyroid cancer	0.000121	0.000275	CcSEcCtD
Citalopram—Agitation—Doxorubicin—thyroid cancer	0.000121	0.000274	CcSEcCtD
Citalopram—Anxiety—Epirubicin—thyroid cancer	0.00012	0.000274	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00012	0.000273	CcSEcCtD
Citalopram—Discomfort—Epirubicin—thyroid cancer	0.000119	0.000271	CcSEcCtD
Citalopram—Malaise—Doxorubicin—thyroid cancer	0.000119	0.000269	CcSEcCtD
Citalopram—Dry mouth—Epirubicin—thyroid cancer	0.000118	0.000269	CcSEcCtD
Citalopram—Vertigo—Doxorubicin—thyroid cancer	0.000118	0.000268	CcSEcCtD
Citalopram—Syncope—Doxorubicin—thyroid cancer	0.000118	0.000268	CcSEcCtD
Citalopram—Leukopenia—Doxorubicin—thyroid cancer	0.000118	0.000267	CcSEcCtD
Citalopram—Confusional state—Epirubicin—thyroid cancer	0.000117	0.000265	CcSEcCtD
Citalopram—Palpitations—Doxorubicin—thyroid cancer	0.000116	0.000264	CcSEcCtD
Citalopram—Oedema—Epirubicin—thyroid cancer	0.000116	0.000263	CcSEcCtD
Citalopram—Anaphylactic shock—Epirubicin—thyroid cancer	0.000116	0.000263	CcSEcCtD
Citalopram—Loss of consciousness—Doxorubicin—thyroid cancer	0.000115	0.000262	CcSEcCtD
Citalopram—Infection—Epirubicin—thyroid cancer	0.000115	0.000262	CcSEcCtD
Citalopram—Cough—Doxorubicin—thyroid cancer	0.000115	0.00026	CcSEcCtD
Citalopram—Shock—Epirubicin—thyroid cancer	0.000114	0.000259	CcSEcCtD
Citalopram—Convulsion—Doxorubicin—thyroid cancer	0.000114	0.000259	CcSEcCtD
Citalopram—Nervous system disorder—Epirubicin—thyroid cancer	0.000114	0.000258	CcSEcCtD
Citalopram—Thrombocytopenia—Epirubicin—thyroid cancer	0.000113	0.000258	CcSEcCtD
Citalopram—Hypertension—Doxorubicin—thyroid cancer	0.000113	0.000258	CcSEcCtD
Citalopram—Tachycardia—Epirubicin—thyroid cancer	0.000113	0.000257	CcSEcCtD
Citalopram—Skin disorder—Epirubicin—thyroid cancer	0.000113	0.000256	CcSEcCtD
Citalopram—Hyperhidrosis—Epirubicin—thyroid cancer	0.000112	0.000255	CcSEcCtD
Citalopram—Arthralgia—Doxorubicin—thyroid cancer	0.000112	0.000254	CcSEcCtD
Citalopram—Myalgia—Doxorubicin—thyroid cancer	0.000112	0.000254	CcSEcCtD
Citalopram—Chest pain—Doxorubicin—thyroid cancer	0.000112	0.000254	CcSEcCtD
Citalopram—Anxiety—Doxorubicin—thyroid cancer	0.000111	0.000253	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000111	0.000252	CcSEcCtD
Citalopram—Discomfort—Doxorubicin—thyroid cancer	0.000111	0.000251	CcSEcCtD
Citalopram—Anorexia—Epirubicin—thyroid cancer	0.00011	0.000251	CcSEcCtD
Citalopram—Dry mouth—Doxorubicin—thyroid cancer	0.000109	0.000249	CcSEcCtD
Citalopram—Hypotension—Epirubicin—thyroid cancer	0.000108	0.000246	CcSEcCtD
Citalopram—Confusional state—Doxorubicin—thyroid cancer	0.000108	0.000246	CcSEcCtD
Citalopram—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000107	0.000244	CcSEcCtD
Citalopram—Oedema—Doxorubicin—thyroid cancer	0.000107	0.000244	CcSEcCtD
Citalopram—Infection—Doxorubicin—thyroid cancer	0.000107	0.000242	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000106	0.00024	CcSEcCtD
Citalopram—Shock—Doxorubicin—thyroid cancer	0.000106	0.00024	CcSEcCtD
Citalopram—Nervous system disorder—Doxorubicin—thyroid cancer	0.000105	0.000239	CcSEcCtD
Citalopram—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000105	0.000239	CcSEcCtD
Citalopram—Insomnia—Epirubicin—thyroid cancer	0.000105	0.000238	CcSEcCtD
Citalopram—Tachycardia—Doxorubicin—thyroid cancer	0.000105	0.000238	CcSEcCtD
Citalopram—Skin disorder—Doxorubicin—thyroid cancer	0.000104	0.000237	CcSEcCtD
Citalopram—Paraesthesia—Epirubicin—thyroid cancer	0.000104	0.000236	CcSEcCtD
Citalopram—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000104	0.000236	CcSEcCtD
Citalopram—Dyspnoea—Epirubicin—thyroid cancer	0.000103	0.000235	CcSEcCtD
Citalopram—Somnolence—Epirubicin—thyroid cancer	0.000103	0.000234	CcSEcCtD
Citalopram—Anorexia—Doxorubicin—thyroid cancer	0.000102	0.000232	CcSEcCtD
Citalopram—Dyspepsia—Epirubicin—thyroid cancer	0.000102	0.000232	CcSEcCtD
Citalopram—Decreased appetite—Epirubicin—thyroid cancer	0.000101	0.000229	CcSEcCtD
Citalopram—Hypotension—Doxorubicin—thyroid cancer	0.0001	0.000228	CcSEcCtD
Citalopram—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.0001	0.000227	CcSEcCtD
Citalopram—Fatigue—Epirubicin—thyroid cancer	9.99e-05	0.000227	CcSEcCtD
Citalopram—Constipation—Epirubicin—thyroid cancer	9.91e-05	0.000225	CcSEcCtD
Citalopram—Pain—Epirubicin—thyroid cancer	9.91e-05	0.000225	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	9.77e-05	0.000222	CcSEcCtD
Citalopram—Insomnia—Doxorubicin—thyroid cancer	9.7e-05	0.00022	CcSEcCtD
Citalopram—Paraesthesia—Doxorubicin—thyroid cancer	9.63e-05	0.000219	CcSEcCtD
Citalopram—Dyspnoea—Doxorubicin—thyroid cancer	9.56e-05	0.000217	CcSEcCtD
Citalopram—Feeling abnormal—Epirubicin—thyroid cancer	9.55e-05	0.000217	CcSEcCtD
Citalopram—Somnolence—Doxorubicin—thyroid cancer	9.53e-05	0.000217	CcSEcCtD
Citalopram—Gastrointestinal pain—Epirubicin—thyroid cancer	9.48e-05	0.000215	CcSEcCtD
Citalopram—Dyspepsia—Doxorubicin—thyroid cancer	9.44e-05	0.000214	CcSEcCtD
Citalopram—Decreased appetite—Doxorubicin—thyroid cancer	9.32e-05	0.000212	CcSEcCtD
Citalopram—Gastrointestinal disorder—Doxorubicin—thyroid cancer	9.26e-05	0.00021	CcSEcCtD
Citalopram—Fatigue—Doxorubicin—thyroid cancer	9.25e-05	0.00021	CcSEcCtD
Citalopram—Urticaria—Epirubicin—thyroid cancer	9.21e-05	0.000209	CcSEcCtD
Citalopram—Constipation—Doxorubicin—thyroid cancer	9.17e-05	0.000208	CcSEcCtD
Citalopram—Pain—Doxorubicin—thyroid cancer	9.17e-05	0.000208	CcSEcCtD
Citalopram—Body temperature increased—Epirubicin—thyroid cancer	9.16e-05	0.000208	CcSEcCtD
Citalopram—Abdominal pain—Epirubicin—thyroid cancer	9.16e-05	0.000208	CcSEcCtD
Citalopram—Feeling abnormal—Doxorubicin—thyroid cancer	8.84e-05	0.000201	CcSEcCtD
Citalopram—Gastrointestinal pain—Doxorubicin—thyroid cancer	8.77e-05	0.000199	CcSEcCtD
Citalopram—Hypersensitivity—Epirubicin—thyroid cancer	8.54e-05	0.000194	CcSEcCtD
Citalopram—Urticaria—Doxorubicin—thyroid cancer	8.52e-05	0.000194	CcSEcCtD
Citalopram—Abdominal pain—Doxorubicin—thyroid cancer	8.48e-05	0.000193	CcSEcCtD
Citalopram—Body temperature increased—Doxorubicin—thyroid cancer	8.48e-05	0.000193	CcSEcCtD
Citalopram—Asthenia—Epirubicin—thyroid cancer	8.32e-05	0.000189	CcSEcCtD
Citalopram—Pruritus—Epirubicin—thyroid cancer	8.2e-05	0.000186	CcSEcCtD
Citalopram—Diarrhoea—Epirubicin—thyroid cancer	7.93e-05	0.00018	CcSEcCtD
Citalopram—Hypersensitivity—Doxorubicin—thyroid cancer	7.9e-05	0.000179	CcSEcCtD
Citalopram—Asthenia—Doxorubicin—thyroid cancer	7.69e-05	0.000175	CcSEcCtD
Citalopram—Dizziness—Epirubicin—thyroid cancer	7.66e-05	0.000174	CcSEcCtD
Citalopram—Pruritus—Doxorubicin—thyroid cancer	7.59e-05	0.000172	CcSEcCtD
Citalopram—Vomiting—Epirubicin—thyroid cancer	7.37e-05	0.000167	CcSEcCtD
Citalopram—Diarrhoea—Doxorubicin—thyroid cancer	7.34e-05	0.000167	CcSEcCtD
Citalopram—Rash—Epirubicin—thyroid cancer	7.31e-05	0.000166	CcSEcCtD
Citalopram—Dermatitis—Epirubicin—thyroid cancer	7.3e-05	0.000166	CcSEcCtD
Citalopram—Headache—Epirubicin—thyroid cancer	7.26e-05	0.000165	CcSEcCtD
Citalopram—Dizziness—Doxorubicin—thyroid cancer	7.09e-05	0.000161	CcSEcCtD
Citalopram—Nausea—Epirubicin—thyroid cancer	6.88e-05	0.000156	CcSEcCtD
Citalopram—Vomiting—Doxorubicin—thyroid cancer	6.82e-05	0.000155	CcSEcCtD
Citalopram—Rash—Doxorubicin—thyroid cancer	6.76e-05	0.000154	CcSEcCtD
Citalopram—Dermatitis—Doxorubicin—thyroid cancer	6.76e-05	0.000153	CcSEcCtD
Citalopram—Headache—Doxorubicin—thyroid cancer	6.72e-05	0.000153	CcSEcCtD
Citalopram—Nausea—Doxorubicin—thyroid cancer	6.37e-05	0.000145	CcSEcCtD
Citalopram—SLC6A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.32e-05	0.00169	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TRIM33—thyroid cancer	1.3e-05	0.00167	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TSHR—thyroid cancer	1.27e-05	0.00162	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PRKAR1A—thyroid cancer	1.24e-05	0.0016	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MINPP1—thyroid cancer	1.24e-05	0.00159	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—TP53—thyroid cancer	1.24e-05	0.00159	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	1.23e-05	0.00158	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—TSHR—thyroid cancer	1.21e-05	0.00155	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—TSHR—thyroid cancer	1.2e-05	0.00154	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—TSHR—thyroid cancer	1.18e-05	0.00152	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	1.16e-05	0.00149	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HPGD—thyroid cancer	1.15e-05	0.00148	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NDUFA13—thyroid cancer	1.15e-05	0.00147	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HPGD—thyroid cancer	1.13e-05	0.00145	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.12e-05	0.00144	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.11e-05	0.00142	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TSHR—thyroid cancer	1.1e-05	0.00141	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TSHR—thyroid cancer	1.09e-05	0.0014	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—PTEN—thyroid cancer	1.09e-05	0.00139	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—SST—thyroid cancer	1.08e-05	0.00139	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CHST14—thyroid cancer	1.08e-05	0.00139	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PRKAR1A—thyroid cancer	1.08e-05	0.00138	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PTCH1—thyroid cancer	1.08e-05	0.00138	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TSHR—thyroid cancer	1.08e-05	0.00138	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	1.08e-05	0.00138	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	1.06e-05	0.00136	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	1.06e-05	0.00136	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PRKAR1A—thyroid cancer	1.06e-05	0.00136	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NDUFA13—thyroid cancer	1.06e-05	0.00136	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CHST14—thyroid cancer	1.05e-05	0.00135	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MINPP1—thyroid cancer	1.05e-05	0.00135	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CALCA—thyroid cancer	1.04e-05	0.00134	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.04e-05	0.00134	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.04e-05	0.00134	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.03e-05	0.00131	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TCF7L1—thyroid cancer	1.02e-05	0.00131	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CHST14—thyroid cancer	9.94e-06	0.00127	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—SST—thyroid cancer	9.84e-06	0.00126	CbGpPWpGaD
Citalopram—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	9.65e-06	0.00124	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CALCA—thyroid cancer	9.47e-06	0.00121	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—SST—thyroid cancer	9.39e-06	0.0012	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—SST—thyroid cancer	9.36e-06	0.0012	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PTCH1—thyroid cancer	9.32e-06	0.00119	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PTCH1—thyroid cancer	9.29e-06	0.00119	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—SST—thyroid cancer	9.21e-06	0.00118	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	9.21e-06	0.00118	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	9.18e-06	0.00118	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PTCH1—thyroid cancer	9.15e-06	0.00117	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	9.15e-06	0.00117	CbGpPWpGaD
Citalopram—SLC6A3—Transmission across Chemical Synapses—HRAS—thyroid cancer	9.05e-06	0.00116	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CALCA—thyroid cancer	9.04e-06	0.00116	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	9.04e-06	0.00116	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CALCA—thyroid cancer	9.01e-06	0.00115	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NDUFA13—thyroid cancer	8.96e-06	0.00115	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CALCA—thyroid cancer	8.87e-06	0.00114	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TCF7L1—thyroid cancer	8.85e-06	0.00113	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TCF7L1—thyroid cancer	8.82e-06	0.00113	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HPGD—thyroid cancer	8.71e-06	0.00112	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TCF7L1—thyroid cancer	8.68e-06	0.00111	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CDK1—thyroid cancer	8.57e-06	0.0011	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—SST—thyroid cancer	8.53e-06	0.00109	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HPGD—thyroid cancer	8.5e-06	0.00109	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—SST—thyroid cancer	8.5e-06	0.00109	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CHST14—thyroid cancer	8.42e-06	0.00108	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—SST—thyroid cancer	8.37e-06	0.00107	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CALCA—thyroid cancer	8.21e-06	0.00105	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	8.2e-06	0.00105	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CALCA—thyroid cancer	8.18e-06	0.00105	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MINPP1—thyroid cancer	8.13e-06	0.00104	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CALCA—thyroid cancer	8.05e-06	0.00103	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HPGD—thyroid cancer	8.01e-06	0.00103	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	7.93e-06	0.00102	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	7.9e-06	0.00101	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.81e-06	0.001	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	7.78e-06	0.000997	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	7.78e-06	0.000997	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TSHR—thyroid cancer	7.47e-06	0.000958	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CDK1—thyroid cancer	7.43e-06	0.000952	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	7.41e-06	0.00095	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—thyroid cancer	7.41e-06	0.00095	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CDK1—thyroid cancer	7.41e-06	0.000949	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKAR1A—thyroid cancer	7.35e-06	0.000943	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	7.29e-06	0.000934	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.15e-06	0.000917	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.07e-06	0.000906	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MEN1—thyroid cancer	7.03e-06	0.000901	CbGpPWpGaD
Citalopram—SLC6A3—Neuronal System—HRAS—thyroid cancer	6.94e-06	0.000889	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NDUFA13—thyroid cancer	6.91e-06	0.000886	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HPGD—thyroid cancer	6.79e-06	0.00087	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6.74e-06	0.000864	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6.72e-06	0.000861	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—TPR—thyroid cancer	6.62e-06	0.000849	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6.61e-06	0.000847	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.56e-06	0.000841	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	6.51e-06	0.000835	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CHST14—thyroid cancer	6.5e-06	0.000833	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—TPR—thyroid cancer	6.49e-06	0.000831	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TSHR—thyroid cancer	6.48e-06	0.00083	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TSHR—thyroid cancer	6.46e-06	0.000828	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	6.38e-06	0.000818	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKAR1A—thyroid cancer	6.37e-06	0.000817	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTCH1—thyroid cancer	6.36e-06	0.000815	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	6.36e-06	0.000815	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKAR1A—thyroid cancer	6.35e-06	0.000814	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	6.25e-06	0.000801	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MEN1—thyroid cancer	6.09e-06	0.000781	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MEN1—thyroid cancer	6.07e-06	0.000778	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	5.98e-06	0.000766	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SST—thyroid cancer	5.81e-06	0.000745	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CALCA—thyroid cancer	5.6e-06	0.000717	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTCH1—thyroid cancer	5.51e-06	0.000706	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.51e-06	0.000706	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.49e-06	0.000704	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTCH1—thyroid cancer	5.49e-06	0.000704	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	5.4e-06	0.000693	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HPGD—thyroid cancer	5.24e-06	0.000671	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CDK1—thyroid cancer	5.07e-06	0.000649	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SST—thyroid cancer	5.04e-06	0.000646	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SST—thyroid cancer	5.02e-06	0.000644	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TPR—thyroid cancer	5e-06	0.000641	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SLC5A5—thyroid cancer	4.96e-06	0.000635	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SST—thyroid cancer	4.94e-06	0.000634	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	4.92e-06	0.000631	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TPR—thyroid cancer	4.88e-06	0.000626	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.88e-06	0.000626	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SLC5A5—thyroid cancer	4.85e-06	0.000622	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CALCA—thyroid cancer	4.85e-06	0.000621	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CALCA—thyroid cancer	4.83e-06	0.000619	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PRKAR1A—thyroid cancer	4.8e-06	0.000616	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	4.76e-06	0.00061	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TPR—thyroid cancer	4.6e-06	0.00059	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	4.53e-06	0.00058	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.46e-06	0.000572	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CDK1—thyroid cancer	4.39e-06	0.000563	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CDK1—thyroid cancer	4.37e-06	0.000561	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	4.31e-06	0.000552	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—RXRA—thyroid cancer	4.16e-06	0.000534	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.12e-06	0.000528	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—RXRA—thyroid cancer	4.08e-06	0.000523	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NRG1—thyroid cancer	4.07e-06	0.000521	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TPR—thyroid cancer	3.9e-06	0.0005	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.84e-06	0.000492	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SLC5A5—thyroid cancer	3.75e-06	0.00048	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SLC5A5—thyroid cancer	3.66e-06	0.000469	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TERT—thyroid cancer	3.65e-06	0.000468	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NRG1—thyroid cancer	3.52e-06	0.000452	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NRG1—thyroid cancer	3.51e-06	0.00045	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.51e-06	0.00045	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	3.49e-06	0.000447	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.48e-06	0.000446	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	3.46e-06	0.000443	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SLC5A5—thyroid cancer	3.45e-06	0.000442	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TERT—thyroid cancer	3.16e-06	0.000405	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TERT—thyroid cancer	3.15e-06	0.000404	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—RXRA—thyroid cancer	3.15e-06	0.000403	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TERT—thyroid cancer	3.1e-06	0.000398	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	3.08e-06	0.000394	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—RXRA—thyroid cancer	3.07e-06	0.000394	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.06e-06	0.000392	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HIF1A—thyroid cancer	3.03e-06	0.000388	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HIF1A—thyroid cancer	3.02e-06	0.000386	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TPR—thyroid cancer	3.01e-06	0.000386	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	2.97e-06	0.00038	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.96e-06	0.000379	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.92e-06	0.000374	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—RXRA—thyroid cancer	2.89e-06	0.000371	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—BRAF—thyroid cancer	2.89e-06	0.000371	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.73e-06	0.000351	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—NRAS—thyroid cancer	2.67e-06	0.000342	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	2.66e-06	0.00034	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.65e-06	0.000339	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARG—thyroid cancer	2.63e-06	0.000337	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	2.62e-06	0.000335	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARG—thyroid cancer	2.58e-06	0.00033	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—BRAF—thyroid cancer	2.51e-06	0.000321	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—BRAF—thyroid cancer	2.5e-06	0.00032	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	2.46e-06	0.000315	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—RXRA—thyroid cancer	2.45e-06	0.000314	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.38e-06	0.000306	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—KRAS—thyroid cancer	2.29e-06	0.000294	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	2.29e-06	0.000293	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.25e-06	0.000289	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	2.25e-06	0.000288	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	2.25e-06	0.000288	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	2.19e-06	0.00028	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCND1—thyroid cancer	2.11e-06	0.00027	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—thyroid cancer	2.07e-06	0.000265	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTEN—thyroid cancer	2.04e-06	0.000261	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—thyroid cancer	2.03e-06	0.00026	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARG—thyroid cancer	1.99e-06	0.000255	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.99e-06	0.000255	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.95e-06	0.00025	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	1.94e-06	0.000249	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARG—thyroid cancer	1.94e-06	0.000249	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.91e-06	0.000245	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.9e-06	0.000243	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—RXRA—thyroid cancer	1.89e-06	0.000243	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	1.89e-06	0.000242	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.86e-06	0.000238	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.83e-06	0.000234	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARG—thyroid cancer	1.83e-06	0.000234	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCND1—thyroid cancer	1.82e-06	0.000234	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.82e-06	0.000233	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTEN—thyroid cancer	1.8e-06	0.000231	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	1.79e-06	0.00023	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTEN—thyroid cancer	1.77e-06	0.000226	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.76e-06	0.000226	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTEN—thyroid cancer	1.76e-06	0.000225	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	1.73e-06	0.000222	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.72e-06	0.000221	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	1.72e-06	0.00022	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	1.69e-06	0.000217	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.57e-06	0.000202	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NRAS—thyroid cancer	1.57e-06	0.000201	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.56e-06	0.0002	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.56e-06	0.0002	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARG—thyroid cancer	1.55e-06	0.000198	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	1.54e-06	0.000198	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—thyroid cancer	1.53e-06	0.000196	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.44e-06	0.000184	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.39e-06	0.000178	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTEN—thyroid cancer	1.36e-06	0.000175	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KRAS—thyroid cancer	1.35e-06	0.000174	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KRAS—thyroid cancer	1.35e-06	0.000173	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTEN—thyroid cancer	1.33e-06	0.000171	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	1.33e-06	0.00017	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.33e-06	0.00017	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTEN—thyroid cancer	1.25e-06	0.000161	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.22e-06	0.000156	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—thyroid cancer	1.2e-06	0.000154	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—thyroid cancer	1.2e-06	0.000154	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARG—thyroid cancer	1.19e-06	0.000153	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—thyroid cancer	1.18e-06	0.000151	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AKT1—thyroid cancer	1.17e-06	0.00015	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HRAS—thyroid cancer	1.15e-06	0.000148	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HRAS—thyroid cancer	1.15e-06	0.000147	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	1.13e-06	0.000145	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTEN—thyroid cancer	1.06e-06	0.000136	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKT1—thyroid cancer	1.04e-06	0.000133	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKT1—thyroid cancer	1.02e-06	0.000131	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT1—thyroid cancer	1.02e-06	0.00013	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT1—thyroid cancer	1.01e-06	0.00013	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	9.98e-07	0.000128	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—thyroid cancer	9.4e-07	0.00012	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTEN—thyroid cancer	8.2e-07	0.000105	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKT1—thyroid cancer	7.86e-07	0.000101	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKT1—thyroid cancer	7.67e-07	9.83e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKT1—thyroid cancer	7.23e-07	9.26e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKT1—thyroid cancer	6.12e-07	7.85e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKT1—thyroid cancer	4.72e-07	6.06e-05	CbGpPWpGaD
